ARK Raises SpaceX Bet as RKLB Momentum Slips, Impacts P-SPAC Outlook
Aug 31, 2026, 3:01 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
SpaceX exposure rising within a high-profile ARK portfolio and a concurrent decline in Rocket Lab momentum may lift SPCX/SpaceX-related SPACs in the near term, as investors chase SpaceX-led growth and diversification away from Rocket Lab.
AI summary
What happened, with direct paths to the underlying reporting
ARK's second-quarter 13F shows a substantial increase in SpaceX exposure, with 4.48 million SpaceX shares valued at roughly $765 million, supporting SPCX after a ~32% monthly rally. Rocket Lab meanwhile prints a Death Cross, signaling waning momentum as ARK trims its RKLB stake by 27%. The shift toward SpaceX within ARK’s space portfolio could affect SPAC-related sentiment and investments in Space-focused SPACs.
ARK increases SpaceX exposure; SPCX up over 30% in the last month.
Rocket Lab trades with a Death Cross; momentum underperforms SpaceX rally.
ARK trims Rocket Lab by 27% to 1.63M shares in 2Q 13F.
ARK adds SpaceX position: 4.48M shares, about $765 million.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event